6/28/2019 Contest update
Biotechs ended the week strong but Q2 remained a losing quarter for the sector. However, despite some rough days for Contest portfolios in Q2, the Contest median only fell about 1%.
At the Q2 close, the Contest median was up 21.91% YTD (vs. up 23.04% at the Q1 close), the Nasdaq Biotech Index (NBI) was up 12.63% YTD (vs. up 15.40% at the Q1 close) and the smaller-cap S&P Biotechnology Select Industry Index (SPSIBI) was up 21.90% YTD (vs. up 25.71% at the Q1 close), while the Nasdaq Composite Index (NCI) was up 20.66% YTD (vs. up 16.49% YTD at the Q1 close).
Contest leader BULBA’s portfolio had another good run, closing the week with a 112.58% YTD gain. KMASTR’s portfolio, up 76.76% YTD, held on to second place and ANDRE’s portfolio, up 74.16% YTD, held on to third place.
At Friday's close, 32 of the 39 Contest portfolios were in the green, while 25 were still beating the NBI and 20 were beating the SPSIBI.
The 167 Contest stock picks have an average YTD gain of 27.51% and a median YTD gain of 13.52%.
Below is the Top Ten list. Also below are the Top 5 & Bottom 5 Stocks for the week ranked by % Gained and % Lost YTD. (Prices not converted to US$ in these Tables.)
Portfolio adjustments: None.
(All corrections, especially adjustments for splits & mergers, greatly appreciated.)
Enjoy a safe & relaxing final June 2019 weekend biotechies!
Peace & good health,
Bulba
P.S. I will post the first half summary tables as soon as I can get to it.
6/28/19
Rank Name Profit/Loss
1 BULBA 112,579
2 KMASTR 76,760
3 ANDRE 74,158
4 OHMS 65,983
5 ARTHUR 63,790
6 BMAZ 63,299
7 HOOD 59,698
8 TRONKA 51,806
9 RKRW 48,041
10 BIOCQR 42,879
Week's Top 5 Gainers
Symbol 6/21/19 6/28/19 Wk.%chg.
KRYS 29.150 40.270 38.15%
SYRS 6.830 9.260 35.58%
NERV 4.230 5.630 33.10%
AGN 130.810 167.430 27.99%
CMRX 3.390 4.320 27.43%
Week's Worst 5 Losers
Symbol 6/21/19 6/28/19 Wk.%chg.
BLCM 2.220 1.700 -23.42%
ALDX 7.420 6.000 -19.14%
GBT 63.000 52.600 -16.51%
EPZM 14.970 12.550 -16.17%
AFMD 3.410 2.870 -15.84%
|
